effect overlay
activetrials
Placeholder
Brain Tumour/Neurosurgery
Brain cancer survivorship - Phase 2

Responding to need: technology-enhanced brain cancer survivorship – Phase 2
 

HREC: 2022.264
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Verena Schadewaldt
Funding: Non-Commercial
Placeholder
Brain Tumour/Neurosurgery
Human Tissue Bank

Supporting Liquid Biopsy for Glioma: A circulating molecular biomarker to diagnose and guide treatment for glioma patients via simple blood test over invasive surgery or tissue biopsies

HREC: 2020.214
Principal Investigator: Dr Stanley Stylli
Coordinator contact: Dr Stanley Stylli
Funding: Non-Commercial
Placeholder
Brain Tumour/Neurosurgery
The molecular drivers of brain metastases

The molecular drivers of brain metastases

HREC: 2021.263
Principal Investigator: Dr Stanley Stylli
Coordinator contact: Dr Stanley Stylli
Funding: Non-Commercial
Placeholder
Brain Tumour/Neurosurgery
Quality of life outcomes

Quality of life outcomes in low-grade glioma and benign brain tumour

HREC: 2013.246
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Sarah Cain
Funding: Non-Commercial
Placeholder
Brain Tumour/Neurosurgery
Post-operative CSF leak

The effects of Cerebrospinal fluid (CSF) diversion on post-operative CSF leak following extended endoscopic anterior skull base surgery

HREC: 2016.234
Principal Investigator: Dr James King
Coordinator contact:
Funding: Non-Commercial